|
|
【FINTEC 0150 交流专区】（前名 ASIABIO）
[复制链接]
|
|
|
发表于 20-9-2017 04:27 AM
|
显示全部楼层
Type | Reply to Query | Reply to Bursa Malaysia's Query Letter - Reference ID | IQL-18092017-00002 | Subject | SUBSCRIPTION OF RIGHTS AND EXCESS SHARES OF MLABS SYSTEMS BERHAD ("MLABS") PURSUANT TO RULE 9.19(26) AND RULE 10.06 OF THE ACE MARKET LISTING REQUIREMENTS ("SUBSCRIPTION") | Description | ASIA BIOENERGY TECHNOLOGIES BERHAD ("ABT" or "the Company")- SUBSCRIPTION OF RIGHTS AND EXCESS SHARES OF MLABS SYSTEMS BERHAD (MLABS) PURSUANT TO RULE 9.19(26) AND RULE 10.06 OF THE ACE MARKET LISTING REQUIREMENTS | Query Letter Contents | We refer to your Company’s announcement dated 15 September 2017, in respect of the aforesaid matter. In this connection, kindly furnish Bursa Securities with the following additional information for public release:- 1. The breakdown of the 75,100,000 MLABS shares acquired between number of shares subscribed via rights and excess shares respectively. 2. The percentage of shareholdings held in MLABS before and after the Subscription. 3. The highest percentage ratios for subscription via excess shares only. | We refer to the announcement dated 15 September 2017 and query letter from Bursa Malaysia Securities Berhad dated 18 September 2017 (Ref.: IQL-18092017-00002) and furnish herewith the following:- |
|
| 1. | The breakdown of the 75,100,000 MLABS shares acquired between number of shares subscribed via rights and excess shares respectively is as follows:- |
|
|
| Type | No. of MLABS shares | Rights | *100,000 | Excess | 75,000,000 |
|
| * Via purchase of rights
| 2. | The percentage of shareholdings held in MLABS before and after the Subscription is as follows:- |
|
Type | % shareholding in MLABS | Before | - | After | 13.16% |
|
| Notes:- a. Prior to the Subscription, ABT does not own any shares in MLABS. b. ABT acquired the subscription rights to 100,000 shares via the open market for a consideration of RM500 on 21 August 2017. c. ABT then subscribed for its entitlement to 100,000 shares and 75,000,000 excess shares at a price of RM0.15 per MLABS share.
| 3. | The highest percentage ratio for subscription, which includes the consideration paid for purchasing the subscription rights via the open market, the consideration paid for the subscription of its entitlement to 100,000 shares, and the consideration paid for the subscription of 75,000,000 excess shares, is 21.25%. |
|
| This announcement is dated 19 September 2017. |
|
|
|
|
|
|
|
|
|
|
|
|
|
发表于 22-9-2017 03:51 AM
|
显示全部楼层
本帖最后由 icy97 于 22-9-2017 11:20 PM 编辑
亚洲生物能源365万售T7全球2.33%
（吉隆坡21日讯）亚洲生物能源（ASIABIO,0150,创业板贸服组）宣布以364万5000令吉在公开市场脱售T7全球（T7GLOBAL,7228,主板贸服组）全部共2.33%股权。
亚洲生物能源在文告中表示，这是配合该公司脱售表现不佳股票的计划，该公司将从中获利3万2413令吉。
文章来源：
星洲日报／财经‧2017.09.22
Type | Announcement | Subject | TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS)
NON RELATED PARTY TRANSACTIONS | Description | ASIA BIOENERGY TECHNOLOGIES BERHAD ("ABT" OR "THE COMPANY")- DISPOSAL OF SHARES IN T7 GLOBAL BERHAD | The Board of Directors of Asia Bioenergy Technologies Berhad (“ABT” or “the Company”) wishes to announce that its wholly-owned subsidiary, Asiabio Capital Sdn. Bhd. that is principally involved in the trading of marketable securities has from 4 May 2017 to 19 September 2017 disposed its entire 2.33% or 8,884,600 ordinary shares of T7 Global Berhad (formerly known as Tanjong Offshore Berhad) (“T7G”) for an aggregate cash consideration of RM3.645 million (“Consideration”) through the open market (hereinafter referred to as the “Disposal”).
Please refer to the attachment below for more details. |
http://www.bursamalaysia.com/market/listed-companies/company-announcements/5551525
|
|
|
|
|
|
|
|
|
|
|
|
发表于 18-10-2017 05:14 AM
|
显示全部楼层
Type | Announcement | Subject | NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS)
FUND RAISING | Description | RIGHTS ISSUE OF ICPS WITH WARRANTS | (For consistency purposes, the abbreviations and definitions used throughout this announcement shall have the same meanings as those previously defined in the announcement dated 11 August 2017 in relation to the Rights Issue of ICPS with Warrants.)
On behalf of the Board, Mercury Securities wishes to announce that the Company has resolved to fix the issue price of the ICPS at RM0.08 per ICPS (“Issue Price”) and the exercise price of the Warrants B at RM0.15 per Warrant B (“Exercise Price”).
The Board had fixed the Issue Price after taking into consideration the following:- (i) the funding requirements of the Group;
(ii) the TEAP of ABT Shares based on the 5-day VWAP of ABT Shares up to and including 16 October 2017, being the last trading day before the price-fixing date (“LTD”); and
(ii) the rationale for the Proposed Rights Issue of ICPS with Warrants, details of which are set out in Section 4 of the circular to shareholders of the Company in relation to the Rights Issue of ICPS with Warrants dated 30 August 2017.
Based on the Issue Price and the Conversion Ratio of 2 ICPS for every 1 new Share, the Conversion Price of RM0.16 represents a discount of approximately 13.24% to the TEAP of ABT Shares of RM0.1844, calculated based on the 5-day VWAP of ABT Shares up to and including the LTD of RM0.2157. The Conversion Price approximates the current market price of ABT Shares.
The Board had fixed the Exercise Price after taking into consideration, amongst others, the TEAP of ABT Shares and the prevailing market prices of ABT Shares. The Exercise Price represents a discount of approximately 18.66% to the aforementioned TEAP.
This announcement is dated 17 October 2017. |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 20-10-2017 04:30 AM
|
显示全部楼层
EX-date | 31 Oct 2017 | Entitlement date | 02 Nov 2017 | Entitlement time | 05:00 PM | Entitlement subject | Rights Issue | Entitlement description | RENOUNCEABLE RIGHTS ISSUE OF UP TO 1,163,208,800 NEW IRREDEEMABLE CONVERTIBLE PREFERENCE SHARES IN ASIA BIOENERGY TECHNOLOGIES BERHAD ("ABT") ("ICPS") AT AN ISSUE PRICE OF RM0.08 PER ICPS TOGETHER WITH UP TO 116,320,880 FREE DETACHABLE WARRANTS IN ABT ("WARRANTS B") ON THE BASIS OF 10 ICPS TOGETHER WITH 1 FREE WARRANT B FOR EVERY 5 EXISTING ORDINARY SHARES IN ABT HELD BY THE ENTITLED SHAREHOLDERS OF ABT AT 5.00 P.M. ON 2 NOVEMBER 2017 ("ENTITLED SHAREHOLDERS") ("RIGHTS ISSUE OF ICPS WITH WARRANTS") | Period of interest payment | to | Financial Year End | 31 Mar 2018 | Share transfer book & register of members will be | to closed from (both dates inclusive) for the purpose of determining the entitlement | Registrar or Service Provider name, address, telephone no | TRICOR INVESTOR & ISSUING HOUSE SERVICES SDN BHDUnit 32-01, Level 32, Tower A,Vertical Business Suite, Avenue 3, Bangsar South,No. 8, Jalan Kerinchi,59200 Kuala LumpurTel:03 2783 9299Fax:03 2783 9222 | Payment date |
| | a.Securities transferred into the Depositor's Securities Account before 4:00 pm in respect of transfers | 02 Nov 2017 | b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit |
| | c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange. | Number of new shares/securities issued (units) (If applicable) |
| | Entitlement indicator | Ratio | Ratio | 2 : 1 | Rights Issue/Offer Price | Malaysian Ringgit (MYR) 0.080 |
Despatch date | 06 Nov 2017 | Date for commencement of trading of rights | 03 Nov 2017 | Date for cessation of trading of rights | 17 Nov 2017 | Date for announcement of final subscription result and basis of allotment of excess Rights Securities | 04 Dec 2017 | Listing Date of the Rights Securities | 11 Dec 2017 |
Last date and time for | Date | Time | Sale of provisional allotment of rights | 16 Nov 2017 | | 05:00:00 PM | Transfer of provisional allotment of rights | 21 Nov 2017 | | 04:00:00 PM | Acceptance and payment | 24 Nov 2017 | | 05:00:00 PM | Excess share application and payment | 24 Nov 2017 | | 05:00:00 PM |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 21-10-2017 06:41 AM
|
显示全部楼层
Type | Announcement | Subject | OTHERS | Description | ASIA BIOENERGY TECHNOLOGIES BERHAD ("ABT" or "the Company")- COLLABORATION AGREEMENT BETWEEN ASIABIO PETROLEUM SDN. BHD. AND ACME INDUSTRIAL SERVICES SDN. BHD. | The Board of Directors of ABT wishes to announce that its wholly-owned subsidiary, Asiabio Petroleum Sdn. Bhd. had on 20 October 2017 entered into a Collaboration Agreement (“Agreement”) with ACME Industrial Services Sdn. Bhd. (Company No. 1222661-P) to cooperate and collaborate to set up a fully integrated blasting and painting yard with complete facilities to specifically target multi-national well service companies contracted to complete the construction of the PETRONAS Refinery and Petrochemical Integrated Development (RAPID) Project within Pengerang Integrated Petroleum Complex (“PIPC”). This may include the blasting and painting and fabrication of pipes and other materials required for the project’s completion.
Please refer to the attachment below for more details. |
http://www.bursamalaysia.com/market/listed-companies/company-announcements/5577597
|
|
|
|
|
|
|
|
|
|
|
|
发表于 15-11-2017 07:44 PM
|
显示全部楼层
本帖最后由 icy97 于 16-11-2017 04:17 AM 编辑
| 0150 ASIABIO ASIA BIOENERGY TECH BHD | | Quarterly Rpt for the Financial Period Ended 30/06/2017 (Amended) | | Quarter: | 1st Quarter | | Financial Year End: | 31/03/2018 | | Report Status: | Unaudited | | Submitted By: |
|
| | | Current Year Quarter | Preceding Year Corresponding Quarter | Current Year to Date | Preceding Year Corresponding Period | | | 30/06/2017 | 30/06/2016 | 30/06/2017 | 30/06/2016 | | | RM '000 | RM '000 | RM '000 | RM '000 | | 1 | Revenue | 1,909 | 1,507 | 1,909 | 1,507 | | 2 | Profit/Loss Before Tax | 39,073 | (7,689) | 39,073 | (7,689) | | 3 | Profit/(loss) attributable to ordinary equity holders of the parent | 39,088 | (7,683) | 39,088 | (7,683) | | 4 | Net Profit/Loss For The Period | 39,073 | (7,689) | 39,073 | (7,689) | | 5 | Basic Earnings/Loss Per Shares (sen) | 10.09 | (0.86) | 10.09 | (0.86) | | 6 | Dividend Per Share (sen) | 0.00 | 0.00 | 0.00 | 0.00 | | | | | As At End of Current Quarter | As At Preceding Financial Year End | | 7 | Net Assets Per Share (RM) | | | 0.2422 | 0.0476 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
发表于 14-12-2017 04:29 AM
|
显示全部楼层
Type | Announcement | Subject | NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS)
FUND RAISING | Description | RIGHTS ISSUE OF ICPS WITH WARRANTS | (For consistency purposes, the abbreviations and definitions used throughout this announcement shall have the same meanings as those previously defined in the Abridged Prospectus of the Company dated 2 November 2017 in relation to the Rights Issue of ICPS with Warrants.)
We refer to the Abridged Prospectus dated 2 November 2017.
On behalf of the Board, Mercury Securities wishes to announce that pursuant to the close of acceptance, excess applications and payment for the ICPS with Warrants B at 5.00 p.m. on 24 November 2017, the Company had received valid acceptances and excess applications for a total of 899,284,472 ICPS, representing 99.85% subscription of the total number of ICPS available for subscription under the Rights Issue of ICPS with Warrants.
Details of such valid acceptances and excess applications received are as follows:- | No. of ICPS | % of total ICPS available for subscription | | Total valid acceptances | 461,874,636 | 51.28 | | Total valid excess applications | 437,409,836 | 48.57 | | Total valid acceptances and excess applications | 899,284,472 | 99.85 | | Total ICPS available for subscription | 900,617,550 | 100.00 | | Remaining ICPS not subscribed for | 1,333,078 | 0.15 |
Successful applicants of the ICPS will be given Warrants B on the basis of 1 Warrant B for every 10 ICPS successfully subscribed for.
The ICPS and Warrants B are expected to be listed on the ACE Market of Bursa Securities on 11 December 2017.
This announcement is dated 4 December 2017. |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 15-12-2017 07:46 AM
|
显示全部楼层
Profile for Securities of PLC| ASIA BIOENERGY TECHNOLOGIES BERHAD |
Instrument Category | Securities of PLC | Instrument Type | Preference Shares | Description | ISSUANCE OF 899,284,472 NEW IRREDEEMABLE CONVERTIBLE PREFERENCE SHARES IN FINTEC GLOBAL BERHAD (FORMERLY KNOWN AS ASIA BIOENERGY TECHNOLOGIES BERHAD) ("FINTEC") ("ICPS") PURSUANT TO THE RENOUNCEABLE RIGHTS ISSUE OF UP TO 1,163,208,800 ICPS AT AN ISSUE PRICE OF RM0.08 PER ICPS TOGETHER WITH UP TO 116,320,880 FREE DETACHABLE WARRANTS IN FINTEC ("WARRANTS B") ON THE BASIS OF 10 ICPS TOGETHER WITH 1 FREE WARRANT B FOR EVERY 5 EXISTING ORDINARY SHARES HELD BY THE ENTITLED SHAREHOLDERS OF FINTEC AT 5.00 P.M. ON 2 NOVEMBER 2017 |
Listing Date | 11 Dec 2017 | Issue Date | 05 Dec 2017 | Issue/ Ask Price | Malaysian Ringgit (MYR) 0.0800 | Issue Size Indicator | Unit | Issue Size in Unit | 899,284,472 | Maturity | Mandatory | Maturity Date | 04 Dec 2027 | Revised Maturity Date |
| | Name of Guarantor | Not Applicable | Name of Trustee | Not Applicable | Coupon/Profit/Interest/Payment Rate | Not Applicable | Coupon/Profit/Interest/Payment Frequency | Not Applicable | Redemption | Not Applicable | Exercise/Conversion Period | 10.00 Year(s) | Revised Exercise/Conversion Period | Not Applicable | Exercise/Strike/Conversion Price | Malaysian Ringgit (MYR) 0.1600 | Revised Exercise/Strike/Conversion Price | Not Applicable | Exercise/Conversion Ratio | 2:1 | Revised Exercise/Conversion Ratio | Not Applicable | Mode of satisfaction of Exercise/ Conversion price | Tendering of securities | Settlement Type/ Convertible into | Physical (Shares) |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 15-12-2017 07:47 AM
|
显示全部楼层
Profile for Securities of PLC| ASIA BIOENERGY TECHNOLOGIES BERHAD |
Instrument Category | Securities of PLC | Instrument Type | Warrants | Description | ISSUANCE OF 89,928,341 FREE DETACHABLE WARRANTS IN FINTEC GLOBAL BERHAD (FORMERLY KNOWN AS ASIA BIOENERGY TECHNOLOGIES BERHAD) ("FINTEC") ("WARRANTS B") ISSUED PURSUANT TO THE RENOUNCEABLE RIGHTS ISSUE OF UP TO 1,163,208,800 NEW IRREDEEMABLE CONVERTIBLE PREFERENCE SHARES IN FINTEC ("ICPS") AT AN ISSUE PRICE OF RM0.08 PER ICPS TOGETHER WITH UP TO 116,320,880 FREE DETACHABLE WARRANTS B ON THE BASIS OF 10 ICPS TOGETHER WITH 1 FREE WARRANT B FOR EVERY 5 EXISTING ORDINARY SHARES HELD BY THE ENTITLED SHAREHOLDERS OF FINTEC AT 5.00 P.M. ON 2 NOVEMBER 2017 |
Listing Date | 11 Dec 2017 | Issue Date | 05 Dec 2017 | Issue/ Ask Price | Not Applicable | Issue Size Indicator | Unit | Issue Size in Unit | 89,928,341 | Maturity | Mandatory | Maturity Date | 04 Dec 2022 | Revised Maturity Date |
| | Name of Guarantor | Not Applicable | Name of Trustee | Not Applicable | Coupon/Profit/Interest/Payment Rate | Not Applicable | Coupon/Profit/Interest/Payment Frequency | Not Applicable | Redemption | Not Applicable | Exercise/Conversion Period | 5.00 Year(s) | Revised Exercise/Conversion Period | Not Applicable | Exercise/Strike/Conversion Price | Malaysian Ringgit (MYR) 0.1500 | Revised Exercise/Strike/Conversion Price | Not Applicable | Exercise/Conversion Ratio | 1:1 | Revised Exercise/Conversion Ratio | Not Applicable | Mode of satisfaction of Exercise/ Conversion price | Cash | Settlement Type/ Convertible into | Physical (Shares) |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 19-12-2017 03:30 AM
|
显示全部楼层
Type | Announcement | Subject | OTHERS | Description | FINTEC GLOBAL BERHAD (Formerly known as Asia Bioenergy Technologies Berhad ("FINTEC" or "the Company")- Clarification on the Article appeared in FocusM, Page 18, Week 9-15 December 2017 entitled "AsiaBios investments bearing fruit" ["Article in FocusM"] | With reference to the Article in FocusM entitled “AsiaBio’s investments bearing fruit”, the Board of Directors of FINTEC wishes to clarify the following:-
i) 8th paragraph in the Article in FocusM – “The parties are expected to enter into a partnership by year-end, says Tan. “We will go into a 50:50 partnership and set up three outlets.” Mr Steve Tan Sik Eek’s statement was referring to the Share Subscription Agreement between NetX Holdings Berhad (“NetX”) and Flavors of Malaysia (“FoM”), which was announced to Bursa Malaysia Securities Berhad (“Bursa Securities”) by NetX on 25 May 2017, where NetX would subscribe equivalent to 51% of the issued and paid-up capital of FoM. The statement was not referring to the Memorandum of Understanding entered between Asiabio Capital Sdn. Bhd., Hong Kong YRZC International Group Co, Ltd, Shan Xi Hong Hui Food Limited Liability Company, and Shan Dong Wang Jia Yuan Zi Halal Food Brewing Co, Ltd. where the business opportunities are still being developed as announced by the Company on 15 November 2017.
ii) 10th paragraph in the Article in FocusM (F&B Lifestyle Hub) – “The Company has set aside around RM60mil for the development of The Arch, a food and beverage (“F&B”) and lifestyle hub located on Jalan Tun Razak, adjacent to TREC Kuala Lumpur. Construction will begin early next year.” Mr Edward Leung Kok Keong’s statement was referring to Focus Dynamics Group Berhad (“Focus”)’s Circular to Shareholders dated 16 August 2017, page 22, where Focus has budgeted a funding requirement of RM60 million for the construction of The Arch.
This announcement is dated 11 December 2017. |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 20-12-2017 01:32 AM
|
显示全部楼层
| ASIA BIOENERGY TECHNOLOGIES BERHAD |
Kindly be advised that the aforesaid Company has changed its name to "FINTEC GLOBAL BERHAD”. As such, the Company's securities will be traded and quoted under the new name with effect from 9.00 a.m., Tuesday, 19 December 2017.
The Stock Short Names will be changed as follow:- Old Name | Old Stock Short Name | New Name | New Stock Short Name | ASIA BIOENERGY TECHNOLOGIES BERHAD | ASIABIO | FINTEC GLOBAL BERHAD | FINTEC | ASIA BIOENERGY TECHNOLOGIES BERHAD -Warrants A 2014/2024 | ASIABIO-WA | FINTEC GLOBAL BERHAD - Warrants A 2014/2024 | FINTEC-WA | ASIA BIOENERGY TECHNOLOGIES BERHAD - Warrants B 2017/2022 | ASIABIO-WB | FINTEC GLOBAL BERHAD - Warrants B 2017/2022 | FINTEC-WB | ASIA BIOENERGY TECHNOLOGIES BERHAD – ICPS A 2017/2027 | ASIABIO-PA | FINTEC GLOBAL BERHAD - ICPS A 2017/2027
| FINTEC-PA |
The Stock Numbers remain unchanged.
|
|
|
|
|
|
|
|
|
|
|
|
发表于 27-12-2017 03:04 AM
|
显示全部楼层
| 1. Details of Corporate Proposal | Involve issuance of new type/class of securities ? | No | Types of corporate proposal | Conversion of Preference Shares | Details of corporate proposal | Conversion of Irredeemable Convertible Preference Shares into Ordinary Shares | No. of shares issued under this corporate proposal | 9,281,266 | Issue price per share ($$) | Malaysian Ringgit (MYR) 0.1600 | Par Value($$) (if applicable) |
| | Latest issued share capital after the above corporate proposal in the following | Units | 461,546,541 | Issued Share Capital ($$) | Malaysian Ringgit (MYR) 71,585,153.660 | Listing Date | 27 Dec 2017 |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 28-12-2017 09:47 PM
|
显示全部楼层
本帖最后由 icy97 于 29-12-2017 12:21 AM 编辑
I PICK THIS CONTRARIAN DEEP UNDERVALUED STOCK FOR 2018
Author: themagicianmerlin | Publish date: Wed, 27 Dec 2017, 12:40 PM
http://klse.i3investor.com/blogs/themagicofmerlin/142511.jsp
Dear investors,
I know if I am saying this, it sounds crazy to you, but that is its fundamental value.
I can say most of investors here don't really understand the model of the Group's operation, that is why the share price has yet react to its fundamental value.
I am quite surprised to see Fintec Global Bhd's latest PE ratio is deep undervalued at only 0.7x after annualising its diluted FY18 EPS and based on current share price of 16sen!
Yes, I noted that its EPS was derived by fair value gain/loss. You would saying that it is not their core or recurring income.
Actually, you are correct as at company level, but at the Group level or as an investment holdings, those fair value are recognisable as part of their net profit because their investments are in position as a business incubator.
Their investment is to help start-up companies they have invested in.
In other words, their operation share similar charateristic with private equity or venture capital but the difference is they also effectively link talent, technology, capital, and know-how in order to leverage entrepreneurial talent and to accelerate the development of companies they have invested in.
This operation is one of kind in local equities market.
The following are local public listed companies they have invested in or we can call them incubatees:
As those companies or incubatees are now making progress towards generating higher profit, their share prices would reflect as well. Thus, the increase in their share prices would contribute higher fair value gain to Fintec's bottomline.
In fact, if they were to dispose their investments, it will translate huge profit to the Fintec's bottomline.
This also would strengthen further its already healthy balance sheet. The Group is in net cash position as of latest quarter results and also remarkable ROE of 27.3%. Meanwhile, its price-to-book value is being trading only at 0.57x.
Contrarian undervalued stock
Soon or later, people will start realise its potential value. Market has discounted the value of this stock too much and it is unfair to the Company.
If I were to play PE ratio just like Mr Koon Yew Yin has been practicing succesfully, this suits well.
So, let's look below for its indicative valuation based on small-cap PE range and its annualised FY18 EPS of 21.86sen.
Remember, if they can do better in the next quarters, its indicative valuation would be even higher than below:
| Price-to-earnings ratio (PE) | Indicative valuation (RM) | | 1x | 0.22 | | 2x | 0.44 | | 3x | 0.66 | | 4x | 0.87 | | 5x | 1.09 |
ConclusionI have done my own compilation and analysis, and my note here is for your reference. My opinion is neither recommending BUY, HOLD nor SELL. |
|
|
|
|
|
|
|
|
|
|
|
发表于 29-1-2018 02:08 AM
|
显示全部楼层
金科全球合理价多少？
投资新手问：
金科全球（FINTEC，0150，创业板贸服组）最近好像有点动静，请问前景如何，合理价多少？
答：金科全球的前身为亚洲生物能源（ASIABIO），主要涉及科技培育领域及投资控股，甫于2017年12月14日更换为现在名称。金科全球前景如何，先探探其最新业绩表现及财务情况，以探出一点端倪。
截至2017年9月30日为止第二季，该公司净利达2075万5000令吉（每股净利4.67仙），前期净利则仅为180万8000令吉（每股净利为0.20仙）。营业额为795万9000令吉，前期为108万7000令吉。
首6个月净利为5984万3000令吉（每股净利为14.38仙），前期则是净亏损587万5000令吉（每股净亏0.64仙），营业额则为986万8000令吉，前期为259万4000令吉。
从上述业绩显示，该公司第二季及首6个月的净利远远超越其营业额，看似有点奇怪，如其第二季营业额仅为795万9000令吉。不过，净利却是高达2075万5000令吉！其实，这主要是公司的投资（特别是股票）增值不少，即中长期投资按市价为准，增值至1905万3000令吉。
财务情况方面，该公司的总资产为1亿4899万7000令吉、流动资产下的贸易及其他应收款项及存款/预付款则为974万9000令吉，投资证券则有796万1000令吉。而非流动资产下的投资证券则达到1亿2436万6000令吉。
另一方面，公司总负债为2445万7000令吉，包括贸易及其他应付款项为2111万7000令吉，借贷为300万8000令吉。
该公司股本为6978万7000令吉，保留盈利为5521万4000令吉。截至2018年1月4日收市时，股价为17.5仙，整个公司的市值为8200万令吉。以上述资料为准，特别是其每股净利为准，将显示其估值非常便宜。
不过，该公司在宣布业绩时也指出，就像其他可交易证券，公司的投资将胥视不可预测的市场力量而定。
由于近年来没有证券研究进行剖析，所以没有合理价推荐。
文章来源：
星洲日报‧投资致富‧投资问诊‧文：李文龙‧2018.01.28 |
|
|
|
|
|
|
|
|
|
|
|
发表于 4-2-2018 09:26 PM
|
显示全部楼层
|
|
|
|
|
|
|
|
|
|
|
发表于 10-2-2018 03:15 AM
|
显示全部楼层
| 1. Details of Corporate Proposal | Involve issuance of new type/class of securities ? | No | Types of corporate proposal | Conversion of Preference Shares | Details of corporate proposal | Conversion of Irredeemable Convertible Preference Shares | No. of shares issued under this corporate proposal | 5,865,300 | Issue price per share ($$) | Malaysian Ringgit (MYR) 0.1600 | Par Value($$) (if applicable) |
| | Latest issued share capital after the above corporate proposal in the following | Units | 475,930,772 | Issued Share Capital ($$) | Malaysian Ringgit (MYR) 73,891,486.930 | Listing Date | 12 Feb 2018 |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 7-3-2018 06:20 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
31 Dec 2017 |
| | INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 31 Dec 2017 | 31 Dec 2016 | 31 Dec 2017 | 31 Dec 2016 | $$'000 | $$'000 | $$'000 | $$'000 |
| 1 | Revenue | 11,261 | 881 | 21,129 | 3,475 | | 2 | Profit/(loss) before tax | 20,014 | -7,933 | 80,170 | -13,819 | | 3 | Profit/(loss) for the period | 20,014 | -7,933 | 79,838 | -13,819 | | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | 20,063 | -7,926 | 79,906 | -13,801 | | 5 | Basic earnings/(loss) per share (Subunit) | 4.44 | -0.83 | 18.67 | -1.44 | | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.4703 | 0.0476
|
|
|
|
|
|
|
|
|
|
|
|
|
发表于 20-3-2018 02:03 AM
|
显示全部楼层
Additional Listing Announcement
| 1. Details of Corporate Proposal | Involve issuance of new type/class of securities ? | No | Types of corporate proposal | Conversion of Preference Shares | Details of corporate proposal | Conversion of Irredeemable Convertible Preference Shares | No. of shares issued under this corporate proposal | 14,000,000 | Issue price per share ($$) | Malaysian Ringgit (MYR) 0.1600 | Par Value($$) (if applicable) |
| | Latest issued share capital after the above corporate proposal in the following | Units | 497,819,772 | Issued Share Capital ($$) | Malaysian Ringgit (MYR) 77,393,726.930 | Listing Date | 20 Mar 2018 | | 2. Details of Corporate Proposal | Involve issuance of new type/class of securities ? | No | Types of corporate proposal | Conversion of Preference Shares | Details of corporate proposal | Conversion of Irredeemable Convertible Preference Shares | No. of shares issued under this corporate proposal | 27,240,000 | Issue price per share ($$) | Malaysian Ringgit (MYR) 0.1600 | Par Value($$) (if applicable) |
| | Latest issued share capital after the above corporate proposal in the following | Units | 525,059,772 | Issued Share Capital ($$) | Malaysian Ringgit (MYR) 81,752,126.930 | Listing Date | 20 Mar 2018 |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 17-4-2018 06:25 AM
|
显示全部楼层
Type | Announcement | Subject | OTHERS | Description | FINTEC GLOBAL BERHAD (f.k.a. Asia Bioenergy Technologies Berhad) ["FINTEC" or "the Company"]- INCORPORATION OF FINTEC GLOBAL (HK) LIMITED, A WHOLLY-OWNED SUBSIDIARY OF THE COMPANY | The Board of Directors of FINTEC wishes to announce that the Company had on 13 April 2018 incorporated a company in Hong Kong under the name of Fintec Global (HK) Limited (“Fintec Global”).
The issued and paid-up capital of Fintec Global is HKD100.00 (Hong Kong Dollars One Hundred), which is equivalent to RM49.42, divided into 100 ordinary shares of HKD1.00 each held entirely by FINTEC.
Fintec Global is intended for the investing and trading in quoted securities and related activities.
The incorporation of Fintec Global will not have any material effects on FINTEC Group’s earnings per share, net assets per share, gearing, share capital and substantial shareholders’ shareholding for the financial year ending 31 March 2019.
None of the Directors and/or major shareholders of the Company and/or persons connected with them have any interest, direct or indirect, in the incorporation.
Having considered all aspects of the incorporation, the Board of Directors of FINTEC is of the opinion that the incorporation is in the best interest of FINTEC.
This announcement is dated 16 April 2018. |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 26-4-2018 02:41 AM
|
显示全部楼层
| 1. Details of Corporate Proposal | Involve issuance of new type/class of securities ? | No | Types of corporate proposal | Conversion of Preference Shares | Details of corporate proposal | Conversion of Irredeemable Convertible Preference Shares | No. of shares issued under this corporate proposal | 1,227,700 | Issue price per share ($$) | Malaysian Ringgit (MYR) 0.1600 | Par Value($$) (if applicable) |
| | Latest issued share capital after the above corporate proposal in the following | Units | 528,819,872 | Issued Share Capital ($$) | Malaysian Ringgit (MYR) 82,353,742.930 | Listing Date | 24 Apr 2018 | | 2. Details of Corporate Proposal | Involve issuance of new type/class of securities ? | No | Types of corporate proposal | Conversion of Preference Shares | Details of corporate proposal | Conversion of Irredeemable Convertible Preference Shares | No. of shares issued under this corporate proposal | 37,200,000 | Issue price per share ($$) | Malaysian Ringgit (MYR) 0.1600 | Par Value($$) (if applicable) |
| | Latest issued share capital after the above corporate proposal in the following | Units | 566,019,872 | Issued Share Capital ($$) | Malaysian Ringgit (MYR) 88,305,742.930 | Listing Date | 24 Apr 2018 | | 3. Details of Corporate Proposal | Involve issuance of new type/class of securities ? | No | Types of corporate proposal | Conversion of Preference Shares | Details of corporate proposal | Conversion of Irredeemable Convertible Preference Shares | No. of shares issued under this corporate proposal | 7,825,600 | Issue price per share ($$) | Malaysian Ringgit (MYR) 0.1600 | Par Value($$) (if applicable) |
| | Latest issued share capital after the above corporate proposal in the following | Units | 573,845,472 | Issued Share Capital ($$) | Malaysian Ringgit (MYR) 89,557,838.930 | Listing Date | 24 Apr 2018 |
|
|
|
|
|
|
|
|
|
|
| |
本周最热论坛帖子
|
2323 
54
